Cyclohexylamine derivative as subtype selective NMDA...

Details Cyclohexylamine derivative as subtype selective NMDA... Cyclohexylamine derivative as subtype selective NMDA...

2005-07-19

2005-07-19

Davis, Zinna Northington (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S357000, C514S619000, C514S621000, C546S329000, C564S161000, C564S163000, C564S169000, C564S170000

Reexamination Certificate

active

06919377

ABSTRACT:
Described are compounds of Formula I and Formula II and their pharmaceutically acceptable salts. The compounds of Formulas I and II are antagonists of NMDA receptor channel complexes useful for treating cerebral vascular disorders such as, for example, cerebral ischemia, cardiac arrest, stroke, and Parkinson's disease.

REFERENCES:
patent: 4438020 (1996-02-01), None
patent: 0507291 (1992-07-01), None
patent: 0940387 (1999-08-01), None
patent: 0982026 (2000-01-01), None
patent: 0000197 (2000-06-01), None
PCT International Search Report, PCT/US01/13176.
Cantarelli et al., “Fenilcicloesilammine E Derivati Nota III—3- e 4-fenilcicloesilammine mono- e disostituite all'azoto Loro attivita anestetica locale e pressoria”, Il Farmaco. Ed. Sc., vol. 25, No. 4, 1970, pp. 248-294.

Affiliated with

Also associated with

Rating

Cyclohexylamine derivative as subtype selective NMDA... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclohexylamine derivative as subtype selective NMDA..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclohexylamine derivative as subtype selective NMDA... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3384128